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Abstract
Amorphous silica nanoparticles (SiNPs) have been extensively used in biomedical applications due to their particular
characteristics. The increased environmental and iatrogenic exposure of SiNPs gained great concerns on the
biocompatibility and hematotoxicity of SiNPs. However, the studies on the hemolytic effects of amorphous SiNPs in
human erythrocytes are still limited. In this study, amorphous SiNPs with 58 nm were selected and incubated with
human erythrocytes for different times (30 min and 2 h) at various concentrations (0, 10, 20, 50, and 100 μg/mL).
SiNPs induced a dose-dependent increase in percent hemolysis and significantly increased the malondialdehyde
(MDA) content and decreased the superoxide dismutase (SOD) activity, leading to oxidative damage in
erythrocytes. Hydroxyl radical (·OH) levels were detected by electron spin resonance (ESR), and the decreased
elimination rates of ·OH showed SiNPs induced low antioxidant ability in human erythrocytes. Na+-K+ ATPase
activity and Ca2+-Mg2+ ATPase activity were found remarkably inhibited after SiNP treatment, possibly causing
energy sufficient in erythrocytes. Percent hemolysis of SiNPs was significantly decreased in the presence of N-acetyl-
cysteine (NAC) and adenosine diphosphate (ADP). It was concluded that amorphous SiNPs caused dose-dependent
hemolytic effects in human erythrocytes. Oxidative damage and energy metabolism disorder contributed to the
hemolytic effects of SiNPs in vitro.
Keywords: Amorphous silica nanoparticles, Hemolytic effects, Human erythrocytes, Oxidative damage, ATPase
activity
Background
Nanotechnology has been rapidly developed as a pioneer
for advanced science in the fields of biology and medi-
cine [1]. Nanomaterials are providing remarkable advan-
tages in medical applications via the efficient absorption
of diverse molecules, including minor drugs, gene vector,
antibiotics, and antibodies [2–5]. Among the top five
widely used engineering nanomaterials, silica nanoparti-
cles (SiNPs) are extensively applied in bioimaging, gene
therapy, and drug delivery [6]. Compared with trad-
itional drugs, the SiNP-based drugs changed pharmaco-
kinetics by increasing solubility and availability [7]. The
benefits of SiNPs in biomedical applications also brought
concerns about the safety of SiNPs, especially in evalu-
ation of blood compatibility and stability since intraven-
ous injection becomes a common iatrogenic exposure
route of SiNPs and SiNPs could directly interact with
the blood components [7, 8].
Erythrocytes are the dominant cell type (90 %) in
blood, and the hemolytic effects of nanoparticles via
direct interaction with erythrocytes have been gaining
growing attentions. Silver nanoparticles (AgNPs) in-
duced size-dependent adsorption, uptake, and hemolytic
activity in Carassius red blood cells (RBCs) [9]. The
endocytosis of mesoporous silica nanoparticles (MSNs)
was clearly observed in various cell lines [10], and a size-
and surface-dependent interaction of MSN with RBCs
has demonstrated a strong affinity and altering mem-
brane shape ability of MSN [11]. However, studies based
on hemolysis assays showed that MSNs (MCM-41-type)
were innocuous compared to amorphous SiNPs [12].
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The hemolytic effects on RBCs were confirmed to be re-
lated to nanoparticle porosity, geometry, and surface
functionality [13]. Although quite a few types of nano-
materials such as mesoporous and nonporous SiNPs [11,
13], TiO2 nanoparticles [14], and polymer nanoparticles
[15] were demonstrated to induce the hemolytic effects
in blood circulation, the research of biocompatibility and
bioavailability of SiNPs still cannot match their rapid
pace of invention and application in new forms.
Erythrocyte species were proven to be related to the
hemolysis of nanoparticles. Diesel exhaust particles
(DEP), as the main component of PM2.5 and ultrafine
particles, were reported to induce slight hemolytic
effects on human erythrocytes (0.7 %) and mouse eryth-
rocytes (2.5 %) but remarkably on rat erythrocytes in a
dose-dependent manner [16]. TiO2 nanoparticles had
the direct hemolytic effect in rabbit erythrocytes [14],
and AgNPs showed prominent hemolytic toxicity in hu-
man blood [17]. Nemmar et al. [18] have proven that
amorphous SiNPs could cause hemolytic effects in
mouse erythrocytes, but it still remains unclear whether
amorphous SiNPs induce hemolysis effects in human
erythrocytes. Therefore, human RBCs were selected to
fully understand the hemocompatibility of amorphous
SiNPs.
Previously, we have noticed that intravenous adminis-
tration of amorphous SiNPs decreased the amount of
RBCs and content of hemoglobin in rats. Moreover, the
occult blood tests and bilirubin in urine were shown
positive (unpublished observations). All these results
suggested that hemolytic anemia might generate in vivo
after SiNP exposure. In in vitro studies, human platelets
were decreased and aggregated by the SiNPs, mostly due
to the consumption and destruction of platelets via
interaction with SiNPs [19, 20]. These findings illus-
trated the urgent need for investigations on the
hemolytic effects of SiNPs in erythrocytes in vitro and
the potential mechanisms of erythrocyte rupture. Many
researches provided evidences that oxidative damage
contributed to the adverse effects of SiNPs [21, 22]. In
our previous studies, we have clarified that oxidative
stress mediated by reactive oxygen (ROS) generation
could induce cell membrane injuries, organelle damage,
and cell death [23, 24]. We also demonstrated that
SiNPs induced a decrease in mitochondrial membrane
potential (MMP) and resulted in cell energy metabolism
disorder, which contributed to apoptotic cell death in
endothelial cells [25]. As a result, we hypothesized that
oxidative stress and adenosine triphosphate (ATP) me-
tabolism disorder were conducive to the erythrocyte
membrane rupture, leading to hemolysis.
As well known, blood is a complex fluid with abun-
dant proteins, ions, and blood cells. The changes on ag-
gregation and dispersion stability of nanoparticles would
be induced by forming “protein coronas” when nanopar-
ticles directly interacted with serum proteins [26]. The
surface property alteration based on blood ionic strength
can also induce nanoparticle agglomerations, which fur-
ther retard cell motility and functions [27]. Fedeli et al.
[28] found that albumin ratio in serum determined the
distinct hemolytic effects of SiNPs on human erythro-
cytes, suggesting serum protein coronas played a role in
promoting hemolysis. However, there are quite a few
studies that chose the protein-free media to create a
controllable condition to focus on the interaction be-
tween the nanoparticles and erythrocytes [11, 29, 30]. In
the present study, human erythrocytes were incubated
with amorphous SiNPs in the serum-free media (phos-
phate-buffered saline (PBS)), and the hemolytic effects
and morphology of erythrocytes were detected. The hy-
droxyl radical (·OH) levels were measured by electron
spin resonance (ESR) to measure ROS accumulations in
erythrocytes. The malondialdehyde (MDA) content and
superoxide dismutase (SOD) activity were further mea-
sured to determine the oxidative damage of erythrocyte
membrane caused by SiNPs. The ROS scavenger N-
acetyl-cysteine (NAC) was selected to elucidate the rela-
tionship between ROS and hemolytic toxicity of
amorphous SiNPs. ATPase activities of erythrocyte
membrane and the protective effect of adenosine di-
phosphate (ADP) in hemolysis were measured to find
out if energy shortage is the potential explanation for
hemolysis induced by amorphous SiNPs.
Methods
Amorphous Silica Nanoparticle Preparation
Amorphous SiNPs were synthesized using the Stöber
method by the School of Chemistry, Jilin University [22].
The morphology characteristics of SiNPs were deter-
mined by transmission electron microscope (TEM)
(JEOL, Japan), and Image J software was used to detect
the size distribution. A zeta electric potential granul-
ometer (Malvern Nano-ZS90, UK) was employed to
measure the zeta potential and hydrodynamic sizes of
SiNPs in PBS. The purity of SiNPs was evaluated by
ICP-OES (Thermo Fisher Scientific, Switzerland). The
endotoxins of SiNPs were detected by gel-clot limulus
amebocyte lysate (LAL) assay.
Blood Collection
Sodium citrate-stabilized human blood samples were
freshly collected from the Clinical Examination Center
of Beijing Xuanwu Hospital, and the project was
approved by the Ethics Committee at Capital Medical
University. Whole blood was centrifuged at 3500 rpm
for 5 min, and packed erythrocytes were isolated from
the plasma. The packed RBCs were washed three times
with PBS (pH 7.4), and after cell washing, 100 μL of
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packed RBCs was diluted to 0.9 mL of PBS to prepare
the RBC suspensions.
Hemolysis Assay Incubated with SiNPs
An amount of 0.2 mL of diluted RBC suspensions was
separately mixed with 0.8 mL of amorphous SiNP sus-
pensions at the concentrations of 12.5, 25, 62.5, and
125 μg/mL, making the final SiNP concentrations at 10,
20, 50, and 100 μg/mL. Double-distilled water and
0.8 mL of PBS were added to 0.2 mL of diluted RBC sus-
pensions as the positive and negative control groups, re-
spectively. All samples were gently vortexed and
prepared in triplicate. The mixtures were incubated at
37 °C for 30 min and 2 h. After incubation, all samples
were centrifuged at 3500 rpm for 5 min. One hundred
microliters of supernatant from the tube was transferred
to a 96-well plate, and the absorbance of hemoglobin
was measured by a microplate reader (Tecan, Australia)
at 577 nm. The percent hemolysis of erythrocytes was
calculated as percent hemolysis (%) = [(sample absorb-
ance − negative control)/(positive control − negative
control)]*100 %.
Erythrocyte Morphology Assessment
An amount of 0.2 mL of diluted RBC suspensions was
incubated at 37 °C for 2 h with amorphous SiNPs at the
final concentrations of 0, 20, 50, and 100 μg/mL. After
incubation, the RBC suspensions were dropped to a slide
glass to make blood smear and fixed with methyl alco-
hol. The slides were stained with Giemsa dye (KeyGEN
Biotech, China) according to the standard techniques
and observed under the optical microscope (Olympus
X71-F22PH, Japan). The magnification is ×400.
Erythrocyte Membrane Isolation
Packed erythrocytes were obtained after the incubation
with SiNPs at the final concentrations of 0, 10, 20, 50,
and 100 μg/mL. Pre-cold lysis buffer (10 mM Tris-HCL,
pH 7.4, and 0.03 mM PMSF) was added into the packed
erythrocytes (volume ratio was about 40:1) and gently
vortexed. The mixtures were incubated at 4 °C over-
night. After incubation, the lytic erythrocytes were cen-
trifuged at 9000 rpm for 20 min and the sediments were
erythrocyte membranes. The membranes were washed
three times with the pre-cold lysis buffer and stored in
PBS solution (pH 7.4) at −20 °C until analysis.
ESR Experiments
The hydroxyl radical (·OH) levels were calculated
according to Fenton reaction. Five microliters of
erythrocyte membrane solutions with different SiNP
concentrations (0, 10, 20, 50, and 100 μg/mL) was added
into the mixture of 5 μL FeSO4 · 7H2O (10 mM) and
5 μL spin-label DMPO (5,5-dimethyl-1-pyrroline N-
oxide) (Sigma, USA). The same volume of PBS buffer
(pH 7.4) was added into the blank tubes. After mixing
well, 5 μL 1 % H2O2 was immediately added into both
sample tubes and blank tubes and reacted for 2 min
before measurement. DMPO–OH adduct was generated
to detect ·OH levels. The mixtures were gently vortexed
and carefully transferred to a VC-H075P plain-type
hematocrit capillary tube (Terumo Corp. Tokyo, Japan)
with an RUVF-203S glass fiber UV irradiator (Radical
Research, Tokyo, Japan, 200 W Hg-Xe lamp). After ir-
radiation, the spectrum of mixed solutions was mea-
sured by a JES TE-100 X-band ESR spectrometer (Jeol,
Tokyo, Japan). The ESR spectra were recorded at 1-mW
microwave power, 335.7-mT center field, ±l7.5-mT
sweep width, and ±0.35-mT modulation width and con-
trolled by a WIN-RAD ESR data analyzer (Radical Re-
search, Tokyo, Japan) via detection of the peak heights
of the spectra. The ·OH elimination rates were calcu-
lated as ·OH elimination rates (%) = [(peak heights of
blank tubes − peak heights of sample tubes)/peak
heights of blank tubes]*100 %.
Oxidative Damage Measurement
An amount of 0.2 mL of diluted RBC suspensions was
incubated at 37 °C for 2 h with amorphous SiNPs at the
final concentrations of 0, 10, 20, 50, and 100 μg/mL.
The mixtures were centrifuged at 3500 rpm for 5 min,
and the supernatants were moved out to get the packed
erythrocytes. Pre-cold double-distilled water was added
to dissolve the erythrocytes, and RBC extraction liquid
was obtained. The malondialdehyde (MDA) contents of
erythrocytes were measured with thiobarbituric acid
method and the superoxide dismutase (SOD) levels were
quantified with hydroxylamine method according to pro-
cedures described in the commercially available kit (Jian-
cheng, China). The absorbance value of MDA was
detected by a UV-vis spectrophotometer (Shimadzu,
Japan) at 532 nm, and the SOD activity was determined
at 550 nm. The hemoglobin concentrations in erythro-
cytes were measured by performing the bicinchoninic
acid (BCA) protein assay (Pierce, USA).
ATPase Activity Assessment
Ten microliters of sodium citrate-stabilized whole blood
was diluted to 90 μL 0.9 % normal saline and briefly vor-
texed. The RBC suspensions were incubated at 37 °C for
2 h with amorphous SiNPs at the final concentrations of
0, 10, 20, 50, and 100 μg/mL. After incubation, the
mixtures were centrifuged at 3500 rpm for 5 min and the
supernatants were moved out to get the packed erythro-
cytes. Five microliters of washed erythrocyte was mixed to
245 μL pre-cold double-distilled water to be fully
dissolved. Na+-K+ ATPase activity and Ca2+-Mg2+ ATPase
activity were determined with molybdenum blue
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spectrophotometric method by detecting the phosphorus
(Pi) content produced by transformation of adenosine tri-
phosphate (ATP) to adenosine diphosphate (ADP). Corre-
sponding assay kits were used (Jiancheng, China). The
absorbance value was detected by a UV-vis spectropho-
tometer (Shimadzu, Japan) at 636 nm. The hemoglobin
concentrations in erythrocytes were measured by per-
forming the BCA protein assay (Pierce, USA).
Fig. 1 Characterization of amorphous SiNPs. a TEM images showed that SiNPs dispersed in PBS appeared to have a spherical shape and good
monodispersity (scale bar 100 nm). b The size distribution of SiNPs showed approximately normal distribution. c Hydrodynamic size distribution
and d zeta potential distribution of SiNPs suspended in PBS
Jiang et al. Nanoscale Research Letters  (2016) 11:57 Page 4 of 12
Hemolysis Assay Added with NAC and ADP
An amount of 0.2 mL of diluted RBC suspensions was
respectively incubated with 0.8 mL of NAC dissolved in
PBS at the final NAC concentrations of 0, 1, 2, 5, and
10 mM/L at 37 °C for 2 h, and the percent hemolysis
was measured. An amount of 0.2 mL of diluted RBC
suspensions was respectively pre-incubated with 0.4 mL
of NAC dissolved in PBS at the final NAC concentra-
tions of 0, 1, 2, 5, and 10 mM/L at 37 °C for 1 h. The
mixtures were added with 0.4 mL of amorphous SiNP
suspensions at the final concentration of 20 μg/mL and
incubated at 37 °C for 2 h. An amount of 0.2 mL of di-
luted RBC suspensions was incubated with 0.8 mL of
amorphous SiNP suspensions at the final concentration
of 100 μg/mL; meanwhile, ADP solutions dissolved in
0.9 % normal saline were added into the suspensions at
the final ADP concentrations of 0, 2, 5, 10, and 20 μM/
L. The mixtures were incubated at 37 °C for 2 h. The
percent hemolysis was measured following the same
procedures described in previous methods.
Statistical Analysis
Data were expressed as mean ± standard deviation (S.D.),
and the significance of statistical comparisons among
groups was determined by one-way analysis of variance
(ANOVA) using SPSS Statistics 21. The normal
distribution of our data was tested before analysis. Dif-
ferences were considered significant at *p < 0.05.
Results
Characterization of Amorphous Silica Nanoparticles
TEM images showed that the amorphous SiNPs ap-
peared to have a spherical shape (Fig. 1a) and the aver-
age size calculated by Image J software was 58.45 ±
7.88 nm, showing approximately normal distribution
(Fig. 1b). The average value of the zeta potential was
−35.3 mV, and the hydrodynamic sizes of SiNPs were
about 95.31 nm, suggesting a good monodispersity in
medium (Fig. 1c, d). The purity of SiNPs was confirmed
higher than 99.9 % [26]. The results of the endotoxin in
SiNP suspensions showed negative.
Hemolytic Effects of SiNPs in Erythrocytes
As seen in Fig. 2, the color of supernatants is gradually
deepening with the increased concentrations of SiNPs
both in the 30-min and 2-h groups, suggesting more
levels of hemoglobin were released from the ruptured
erythrocytes induced by a higher dose of SiNPs. To
quantify the hemolytic effects of SiNPs in human eryth-
rocytes, percent hemolysis was calculated. The percent
hemolysis of erythrocytes induced by SiNPs showed no
significant changes at the concentration of 10 μg/mL at
Fig. 2 Photographs and percent hemolysis of human erythrocytes. Human erythrocytes were incubated with amorphous SiNPs at different
concentrations ( 0, 10, 20, 50, and 100 μg/mL) for different exposure times (30 min and 2 h). Double-distilled water (+) and PBS (−) were used as
positive and negative controls, respectively. Percent hemolysis (%) = [(sample absorbance − negative control)/(positive control − negative
control)]*100 %. Data are expressed as mean ± S.D., *p < 0.05 vs the control group
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30 min and 2 h, but at 20 μg/mL, the percent hemolysis in
two time points showed significant increases in a dose-
dependent manner (p < 0.05). Particularly mentioned, in
the 100 μg/mL SiNP-treated groups, the percent
hemolysis showed significant elevation after a 2-h incuba-
tion compared to the 30-min incubation (p < 0.05). Our
results suggested SiNPs induced the hemolytic effects in
human erythrocytes in a dose-dependent manner and the
hemolysis increased remarkably after longer time
exposure.
Effects of SiNPs on Erythrocyte Morphology
Figure 3 shows erythrocyte morphology at ×400 magnifi-
cation after SiNP incubation with different concentra-
tions (0, 20, 50, and 100 μg/mL). The erythrocytes in the
control group displayed a typical concave disk and rela-
tively uniform shape, size, and color. In the group of
SiNPs, erythrocytes appeared swollen (arrows) and to
have an irregular shape (triangles) and even membrane
fragments (five-point stars). The density of erythrocytes
in views was gradually reduced, which might explain that
erythrocytes were disrupted by SiNPs.
Effects of SiNPs on ·OH Elimination
To detect the ROS generation induced by SiNPs in hu-
man erythrocytes, ·OH levels of erythrocyte membranes
were measured by ESR. Under the physiological
conditions, the balance between the generation and
elimination of ·OH can be maintained by the oxidation-
antioxidation systems. As seen in Fig. 4, the spectrum
peaks showed a gradually increased trend, indicating
high levels of ·OH accumulation, giving evidences that
the ability to eliminate ·OH in erythrocytes was inhib-
ited. The elimination rates of ·OH were calculated to
quantify the low activities of the antioxidation system.
As it turned out from 20 μg/mL, SiNPs induced a dose-
dependent decrease in the ·OH elimination rates and
showed significant differences compared to the control
group (p < 0.05).
Effects of SiNPs on the MDA Content and SOD Activity
To get further knowledge about the mechanisms of
erythrocyte membrane disruption, we measured the
MDA content and SOD activity after SiNP incubation at
different concentrations. As shown in Fig. 5a, b, at the
low concentration of SiNPs (10 μg/mL), there were no
significant differences in the MDA content and SOD ac-
tivity between the control and SiNP-treated groups,
which was quite consistent with the effect of SiNPs on
erythrocyte hemolysis. Figure 5a shows that SiNPs in-
duced a dose-dependent increase in MDA concentra-
tions and the effects were significant in the groups of 20,
50, and 100 μg/mL (p < 0.05). Contrary to the MDA
levels, the SOD activity showed a decreased trend with
Fig. 3 Giemsa staining of human erythrocyte smears. Human erythrocytes were incubated with amorphous SiNPs for 2 h at different
concentrations ( 0, 10, 20, 50, and 100 μg/mL). Arrows represented the swelling erythrocytes; triangles represented the deformed erythrocytes;
five-point stars represented the erythrocyte membrane fragments. The magnification was ×400. Scale bars are 50 μm
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the increased dose of SiNPs and the significances in com-
parison with the control group were discovered from
20 μg/mL to the highest levels (100 μg/mL) (p < 0.05)
(Fig. 5b). The changes on the MDA content and SOD ac-
tivity suggested amorphous SiNPs could cause oxidative
damage in human erythrocytes, which was mainly respon-
sible for erythrocytes hemolysis.
Effects of SiNPs on ATPase Activities
To measure the effects of SiNPs on energy
metabolism of erythrocyte membrane, Na+-K+ ATPase
and Ca2+-Mg2+ ATPase activity were detected. Data
from Fig. 6a reveals a remarkable decrease in Na+-K+
ATPase activity in a dose-dependent manner, and it
was down-regulated significantly in the groups of 20,
50, and 100 μg/mL compared to the control group (p
< 0.05). As shown in Fig. 6b, Ca2+-Mg2+ ATPase ac-
tivity was decreased in 10 μg/mL, but not signifi-
cantly. At 20 to 100 μg/mL, there were significant
differences in Ca2+-Mg2+ ATPase activity between the
SiNP-treated groups and the control group (p < 0.05).
Our results revealed that SiNPs could damage
erythrocyte membranes by disturbing the ATPase ac-
tivities and inducing the ATP metabolism disorder.
Protection of NAC and ADP on Erythrocytes Hemolysis
We have noticed that ROS accumulation and oxidative
damage might get involved in the erythrocyte membrane
disruption; therefore, we chose NAC, which is an oxygen
inhibitor to testify that oxidative stress contributed to
hemolysis induced by SiNPs. Table 1 shows that there
was no significant difference in percent hemolysis
Fig. 4 Effects of amorphous SiNPs on hydroxyl radical (·OH) elimination. a ESR spectra of ·OH in human erythrocyte membranes incubated with
SiNPs for 2 h at different concentrations (0, 10, 20, 50, and 100 μg/mL). b ·OH elimination rates calculated as [(peak heights of blank tubes − peak
heights of samples)/peak heights of blank tubes]*100 %. Data are expressed as mean ± S.D., *p < 0.05 vs the control group
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between groups only incubated with NAC (0, 1, 2, 5, and
10 mM/L), suggesting that NAC itself was incapable of
inducing hemolysis. Figure 7 indicates that in the SiNP-
treated groups with NAC, percent hemolysis showed an
obvious dose-dependent decrease, and it was noteworthy
that all groups in the presence of NAC showed signifi-
cant differences compared to the control group in the
absence of NAC (p < 0.05). Our data demonstrated that
NAC successfully reduced the oxidative damage and
played a protective role in the hemolytic effects of SiNPs
in human erythrocytes.
Figure 8 shows the effects on percent hemolysis of hu-
man erythrocytes after SiNP incubation with ADP. From
our results, the hemolysis was significantly decreased at
the ADP concentrations of 10 and 20 μM/L (p < 0.05),
which suggested that as a synthesis source of ATP, ADP
was conducive to reduce the hemolytic effects of SiNPs.
In other words, ATP shortage caused by ATPase activity
damage is a reasonable explanation for hemolysis in-
duced by SiNPs.
Discussion
The bloodstream exposure to SiNPs through environ-
mental and iatrogenic routes arouses great concerns
on the biocompatibility and hemostability of SiNPs.
In a previous study, we have noticed that SiNPs could
induce hemolytic anemia in vivo (unpublished data),
and to further clarify the hemolytic potentials of
SiNPs on erythrocytes and the propensity to induce
RBC membrane deformation or morphological alter-
ation, the hemolysis assay in vitro was performed.
PBS which is protein-free and isotonic to the blood
was selected as the culture solution to strip out the
impact of proteins and ions on SiNP characterization.
As mentioned above, erythrocyte species probably
acted as an important impact factor for hemolytic activ-
ity of nanoparticles. The difference in amplitude of the
hemolytic effects was explained due to the different sus-
ceptibility of nanoparticles interacting with erythrocyte
membrane of various species [16]. In the present study,
amorphous SiNPs ruptured human erythrocytes and led
Fig. 5 Effects of amorphous SiNPs on oxidative damage. Human erythrocytes were incubated with SiNPs for 2 h at different concentrations (0, 10,
20, 50, and 100 μg/mL). a Malondialdehyde (MDA) content. b Superoxide dismutase (SOD) activity. Data are expressed as mean ± S.D., *p < 0.05 vs
the control group
Fig. 6 Effects of amorphous SiNPs on ATPase activities. Human erythrocytes were incubated with SiNPs for 2 h at different concentrations (0, 10,
20, 50, and 100 μg/mL). a Na+-K+ ATPase activity. b Ca2+-Mg2+ ATPase activity. Data are expressed as mean ± S.D., *p < 0.05 vs the control group
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to significant hemolysis (Fig. 2), indicating human
erythrocyte membrane was sensitive to amorphous
SiNPs. It has been reported that amorphous SiNPs in-
duced dose-dependent hemolysis in mice [18]; however,
we testified the hemolytic effects of SiNPs on human
RBCs, providing new insight for safety evaluation of
SiNPs. In order to find out if time extension affected the
hemolysis in erythrocytes, we tested the percent
hemolysis at different time points (30 min and 2 h) after
SiNP exposure. It turned out that the hemolysis was en-
hanced as the exposure time elongated (Fig. 2).
Red cell membrane rupture or the matrix dissoci-
ation are the essential reasons for hemolysis to occur.
In various cell lines, it was confirmed that amorphous
SiNPs induced cytotoxicity via the disruption of cell
membrane integrity and the collapse of the cytoskel-
eton [31–33]. Cell membrane permeability is usually
measured by lactic dehydrogenase (LDH) activity in
cell medium, which is an effective indictor for
irreversible cell death. According to our previous
study, LDH activity showed a dose-dependent increase
both in human endothelial cells [32] and the erythro-
cyte supernatants after amorphous SiNP incubation
(unpublished observations). These results showed evi-
dences that SiNPs exerted hemolytic effects via in-
creasing the erythrocyte membrane permeability and
promoting red cell rupture. The morphological obser-
vation of erythrocytes via Giemsa staining found that
amorphous SiNPs could cause erythrocyte deform-
ation, cell swelling, and cytomembrane damage or
even rupture (Fig. 3).
To further investigate the potential mechanisms of
erythrocyte membrane rupture caused by SiNPs, the oxi-
dative damage in human erythrocytes was measured. Oxi-
dative stress is a consequence of imbalances in oxidation
and antioxidation. Oxidative damage was considered as a
common toxic mechanism of SiNPs for decreasing cell
viability and breaking membrane integrity [34]. Owing to
specific physicochemical properties, the SiNPs did not
only generate spontaneous ROS at the surface but also
triggered free oxygen radicals on cells [24]. The persistent
accumulation of ROS induced by SiNPs could result in
peroxidation of cell components like proteins, lipids, and
DNA and decrease cellular antioxidant activity [23]. Hy-
droxyl radical (·OH) is one kind of important and highly
active ROS, which was generally accepted as the main
cause of biological damage [35]. It was demonstrated that
both quartz and vitreous silica stably induced surface radi-
cals and sustained release of ·OH [36]. Amorphous SiNPs
up-regulated heme oxygenase-1 (HO-1) mRNA expres-
sion in endothelial cells, and ·OH production induced by
SiNPs was considered as the primary cause for the de-
creased cell viability [37]. The decreased ·OH elimination
Table 1 Percent hemolysis of human erythrocytes after NAC
pretreatment
Group Concentration (mM/L) Percent hemolysis (%)
Control 0 0.000 ± 0.047
NAC 1 0.179 ± 0.111
2 −0.099 ± 0.121
5 −0.040 ± 0.090
10 −0.051 ± 0.018
Data are expressed as mean ± S.D.
*p < 0.05 vs the control group
Fig. 7 Effects of N-acetyl-cysteine (NAC) on percent hemolysis.
Human erythrocytes with the pretreatment of NAC at different
concentrations (0, 1, 2, 5, and 10 mM/L) were incubated with
amorphous SiNPs of 20 μg/mL for 2 h. Data are expressed as mean
± S.D., *p < 0.05 vs the control group
Fig. 8 Effects of adenosine diphosphate (ADP) on percent hemolysis.
Human erythrocytes with treatment of ADP at different
concentrations (0, 2, 5, 10, and 20 μM/L) were incubated with
amorphous SiNPs of 100 μg/mL for 2 h. Data are expressed as
mean ± S.D., *p < 0.05 vs the control group
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rates in our study indicated that SiNPs inhibited the anti-
oxidant activity to facilitate ROS accumulation and ·OH
played an active role in hemolysis (Fig. 4). MDA is a final
product of lipid peroxidation, generated from the peroxi-
dation of polyunsaturated fatty acid (PUFA) attacked by
the free radicals [38]. Moreover, the more free radicals
were produced, the more serious lipid peroxidation and
oxidative damage in cell functions were induced. In gen-
eral, MDA is treated as a reliable indicator to measure the
oxidative damage [38]. It was reported that lipid peroxide
was treated as key process to erythrocyte membrane dis-
ruption after exposure to DEP [16] and incubation of
mouse erythrocytes with SiNPs (50 nm) caused significant
increase in the MDA content [18], which were fairly con-
sistent with our results of the MDA content (Fig. 5a).
These findings suggested that erythrocyte membrane was
a direct target that SiNPs interacted with and the lipid
peroxidation of membrane was a potential mechanism of
membrane damage. SOD is a kind of antioxidant enzyme
which plays a vital role in maintaining oxidative homeo-
stasis. Previously, we have reported that amorphous SiNPs
induced a significant decrease in SOD activity and gluta-
thione peroxidase (GSH-PX) activity in human umbilical
vein endothelial cells (HUVECs), leading to endothelial in-
jury, cell autophagy, and apoptosis [23–25]. Herein, the
decreased SOD activity (Fig. 5b) demonstrated the insuffi-
cient antioxidant ability of erythrocytes to resist the oxida-
tion induced by SiNPs, resulting in erythrocyte damage
and rupture. To further elucidate the relationship between
ROS and hemolysis in erythrocytes, N-acetyl-cysteine
(NAC) which is a regular scavenger of ROS was added to
alter the percent hemolysis of SiNPs. The ROS toxicity
can be eliminated via combination of the ROS electro-
philic groups with the NAC sulfhydryl group. Moreover,
NAC is a precursor of glutathione, playing important roles
in antioxidation owing to its good permeability to cell
membrane [39, 40]. The resistance of NAC in oxidative
damage towards nanomaterials has been well docu-
mented, and cell multinucleation and autophagy induced
by amorphous SiNPs were remarkably alleviated by NAC
[25, 41]. Accordingly, the percent hemolysis showed a
dose-dependent decrease after NAC treatment (Fig. 7),
suggesting that ROS generation was closely related to the
hemolysis in erythrocytes. Our data suggested that
amorphous SiNPs induced a dose-dependent ROS pro-
duction, leading to the lipid peroxidation and oxidative
damage of erythrocyte membrane, consequently causing
hemolysis.
Endocytosis was considered as the common way in-
volved in the interaction of SiNPs with the red cell
membrane [10, 42], and the occurrence of endocytosis
relied heavily on the released energy on the surface of
the membrane and the deformability of the mem-
brane [43]. To measure the energy metabolism of
erythrocytes in our study, Na+-K+ ATPase and Ca2
+-Mg2+ ATPase activities were detected. Na+-K+
ATPase is a membranous protein, which is capable of
providing energy released from ATP hydrolysis and
maintaining the ion concentration gradients across
the membrane of low Na+ levels inside and low K+
levels outside the cells [44, 45]. The insufficiency and
exhaust of ATP was a potential toxic mechanism of
erythrocyte caducity by inducing abnormal ion
transport, energy metabolism suffocation, and de-
clined erythrocyte deformability [46]. It was demon-
strated that zinc oxide nanoparticles (ZnO) decreased
the Na+-K+ ATPase activity in freshwater fish leading
to epithelial permeability increase and structure re-
modeling [47]. In addition, silver nanoparticles
(AgNPs) inhibited the Na+-K+ ATPase and erythrocyte
acetylcholinestrase (AChE) activities, resulting in im-
proper ion regulation and energy imbalance [48]. The
decreased Na+-K+ ATPase activity (Fig. 6a) suggested
that amorphous SiNPs could reduce the capacity of
energy generation in human erythrocytes, followed by
red cell membrane dysfunction and disruption. Mem-
brane calcium ion (Ca2+) ATPase is a high-affinity
Ca2+ pump which takes charge of the regulation of
intracellular Ca2+ levels and releases energy from
driving Ca2+ out of cells [49]. Ca2+ participates in the
regulation of various vital functions in cells, such as
cell signal transduction, differentiation, and metabol-
ism [50]. Wu et al. found that TiO2 nanoparticle
could efficiently inhibit the cell proliferation in hu-
man lens epithelial cells via disruption of calcium
homeostasis of elevating intracellular Ca2+ and inhi-
biting Ca2+ ATPase activities [51]. The exposure of
rat erythrocytes to amorphous SiNPs caused remark-
able increase in intracellular Ca2+ levels and Annexin
V expression which is a Ca2+-dependent binding pro-
tein, leading to apoptosis of erythrocytes [18]. Ca2+
ATPase was confirmed to be susceptible to oxidative
damage because of the sulfhydryl structure, and thus,
Ca2+ ATPase activities were sensitive to the oxidative
homeostasis alteration [52]. In the present study,
SiNPs inhibited the Ca2+-Mg2+ ATPase activity in
human erythrocytes (Fig. 6b), possibly because of the
high intracellular Ca2+ levels and interference effects
of oxidative stress. ADP is a source for synthesis of
ATP, and the decreased percent hemolysis of SiNPs in
erythrocytes incubated with ADP (Fig. 8) was persua-
sive that ATP was necessary for maintaining mem-
brane integrity. Combined with the damage of Na+-K+
ATPase and Ca2+-Mg2+ ATPase activities and the
protective effects of ADP on hemolysis, we believed
that energy metabolism imbalance and ion channel
dysfunction of erythrocyte membrane were largely ac-
countable for hemolysis induced by amorphous SiNPs.
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Conclusions
It was concluded that amorphous SiNPs caused dose-
dependent hemolytic effects and remarkably altered the
shape and deformability of erythrocytes. The abilities of
·OH elimination were inhibited by SiNPs to facilitate ROS
accumulation in erythrocytes, and ·OH played an active
role in hemolysis. SiNPs induced a dose-dependent ROS
production, leading to oxidative damage of erythrocyte
membrane by increasing the lipid peroxidation and
decreasing the antioxidant ability, consequently causing
hemolysis. ATPase activities were inhibited, and the
energy metabolism disorder of membrane contributed to
the hemolytic effects of SiNPs in human erythrocytes. Our
findings provided a new vision to lucubrate the hemato-
toxicity of amorphous SiNPs, but the mechanism in depth
of hemolysis and the risk assessment and safety evaluation
of SiNPs in biomedical applications are still needed.
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